A Pharmacist’s Guide to Statin Therapy
Monograph
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Want another way to take this test? Check out the video-based version of this course.
Course Summary
Heart disease is the leading cause of death in the United States, and atherosclerotic cardiovascular disease is a significant contributor to mortality and morbidity. Decades of randomized control trials have demonstrated a complex relationship between atherosclerotic cardiovascular disease and lipoproteins. Lipoprotein levels can be modified pharmacologically to lower the risk of atherosclerotic cardiovascular disease and mortality. This can be accomplished safely and successfully using lipid-lowering medications, including statins. Pharmacists must be familiar with the various statin drugs and their indications and guidelines so they may recommend the best treatment option to their patients.
Course Objectives
Recall current guideline recommendations for use of lipid-lowering medications
Identify indications, side effect profiles, and monitoring recommendations for statins
Discuss how to collaborate with prescribers to establish optimal lipid-lowering regimens
I. Introduction
II. Prevalence of Heart Disease
III. Lipoproteins: The Good, The Bad, and the Ugly
IV. Lipid Pathophysiology and Atherosclerotic Cardiovascular Disease
V. ASCVD: Who is at Risk?
VI. Statins: First-line Lipid-Lowering Therapy
VII. Who Needs a Statin: Using the Latest Guidelines
VIII. Secondary Prevention
IX. Healthy Lifestyle: Before, During, and After Statins
X. Statin Comparisons
1. Administration of Statins
2. Cost
XI. Statin Adverse Events
XII. Monitoring Statin Therapy
Addressing Patient Concerns
XIII. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in the development of this activity: L. Austin Fredrickson, MD, FACP, and Susan DePasquale, MSN, PMHNP-BC. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
- Target Audience: Pharmacist
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 12/17/2022
- Activity Expiration Date: 12/17/2025
- Activity Type: Knowledge
- UAN: 0669-0000-22-093-H01-P
- Topic: Disease State Management/Drug Therapy
- CeBroker Number: 20-997338
Author:
Preview the Materials:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.